Device Trial Radar · NCT01091883
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Mar 13, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
May 2010
Primary completion
Jan 2019
Study completion Mar 2019
Sponsor
- Lead sponsor
- InSightecNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 24, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to collect comparative data on safety and efficacy of MR Guided Focused Ultrasound and External Beam Radiation for treatment of metastatic bone tumors or multiple myeloma.
Conditions
- Bone Cancer
- Bone Metastases
- Pain
Interventions
Exablate treatmentDevice
MR Guided Focused Ultrasound
RadiationRadiation
External Beam Radiation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of treatmentTime frame: 6 months
- NRS scoreTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Taipei Medical University Hospital
Taipei City, Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.